The Diagnostic Accuracy of Combined Enolase/Cr, CA125, and CA19-9 in the Detection of Endometriosis

Table 5

Marker levels and clinical characteristics of patients with endometriosis ().

Variable		(%)	Urinary enolase 1 ng/mL	Enolase-Cr (ng/mg Cr)	CA125 (IU/mL)	CA19-9 (IU/mL)
			Age (years)	<30	17 (36.2)
30–39	20 (42.6)
≥40	10 (21.3)
value		—	0.610	0.567	0.378	0.509
BMI (kg/m^2)	<24.9	20 (42.6)
	≥24.9	27 (57.4)
value		—	0.493	0.345	0.420	0.176
Stage of endometriosis	Stage I + II	8 (17)
	Stage III + IV	39 (83)
p value		—	0.819	0.575	0.795	0.274
CA125 (35 U/mL)	≤35	14 (29.8)			—
	>35	33 (70.2)			—
p value		—	0.567	0.378	—	<0.001
Menstrual phase	Follicular phase	29 (61.7)
	Luteal phase	18 (38.3)
value		—	0.017	0.039	0.091	0.712
Infertility	Yes	19 (40.4)
	No	28 (59.6)
value		—	0.480	0.503	0.422	0.885

Results of the ANOVA test; results of the Mann-Whitney test.